TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2015 DA - 2015// TI - Cancer statistics, 2015 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21254 DO - 10.3322/caac.21254 ID - Siegel2015 ER - TY - JOUR AU - Markman, M. AU - Markman, J. AU - Webster, K. AU - Zanotti, K. AU - Kulp, B. AU - Peterson, G. PY - 2004 DA - 2004// TI - Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.195 DO - 10.1200/JCO.2004.05.195 ID - Markman2004 ER - TY - JOUR AU - Sabbatini, P. AU - Odunsi, K. PY - 2007 DA - 2007// TI - Immunologic approaches to ovarian cancer treatment JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.11.0775 DO - 10.1200/JCO.2007.11.0775 ID - Sabbatini2007 ER - TY - JOUR AU - June, C. H. AU - Maus, M. V. AU - Plesa, G. AU - Johnson, L. A. AU - Zhao, Y. AU - Levine, B. L. PY - 2014 DA - 2014// TI - Engineered T cells for cancer therapy JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1568-1 DO - 10.1007/s00262-014-1568-1 ID - June2014 ER - TY - JOUR AU - Couzin-Frankel, J. PY - 2013 DA - 2013// TI - Breakthrough of the year 2013 JO - Cancer Immunother Sci VL - 342 ID - Couzin-Frankel2013 ER - TY - JOUR AU - Hwang, W. T. AU - Adams, S. F. AU - Tahirovic, E. AU - Hagemann, I. S. AU - Coukos, G. PY - 2012 DA - 2012// TI - Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis JO - Gynecol Oncol VL - 124 UR - https://doi.org/10.1016/j.ygyno.2011.09.039 DO - 10.1016/j.ygyno.2011.09.039 ID - Hwang2012 ER - TY - JOUR AU - Sato, E. AU - Olson, S. H. AU - Ahn, J. AU - Bundy, B. AU - Nishikawa, H. AU - Qian, F. PY - 2005 DA - 2005// TI - Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0509182102 DO - 10.1073/pnas.0509182102 ID - Sato2005 ER - TY - JOUR AU - Hamanishi, J. AU - Mandai, M. AU - Iwasaki, M. AU - Okazaki, T. AU - Tanaka, Y. AU - Yamaguchi, K. PY - 2007 DA - 2007// TI - Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0611533104 DO - 10.1073/pnas.0611533104 ID - Hamanishi2007 ER - TY - JOUR AU - Mariya, T. AU - Hirohashi, Y. AU - Torigoe, T. AU - Asano, T. AU - Kuroda, T. AU - Yasuda, K. PY - 2014 DA - 2014// TI - Prognostic impact of human leukocyte antigen class I expression and association of platinum resistance with immunologic profiles in epithelial ovarian cancer JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0101 DO - 10.1158/2326-6066.CIR-14-0101 ID - Mariya2014 ER - TY - JOUR AU - Paroli, M. AU - Bellati, F. AU - Videtta, M. AU - Focaccetti, C. AU - Mancone, C. AU - Donato, T. PY - 2014 DA - 2014// TI - Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells JO - Int J Cancer VL - 134 UR - https://doi.org/10.1002/ijc.28515 DO - 10.1002/ijc.28515 ID - Paroli2014 ER - TY - JOUR AU - Curiel, T. J. AU - Coukos, G. AU - Zou, L. AU - Alvarez, X. AU - Cheng, P. AU - Mottram, P. PY - 2004 DA - 2004// TI - Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1093 DO - 10.1038/nm1093 ID - Curiel2004 ER - TY - JOUR AU - Parker, J. N. AU - Gillespie, G. Y. AU - Love, C. E. AU - Randall, S. AU - Whitley, R. J. AU - Markert, J. M. PY - 2000 DA - 2000// TI - Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.040557897 DO - 10.1073/pnas.040557897 ID - Parker2000 ER - TY - JOUR AU - Hellums, E. K. AU - Markert, J. M. AU - Parker, J. N. AU - He, B. AU - Perbal, B. AU - Roizman, B. PY - 2005 DA - 2005// TI - Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model JO - Neuro-Oncology VL - 7 UR - https://doi.org/10.1215/S1152851705000074 DO - 10.1215/S1152851705000074 ID - Hellums2005 ER - TY - JOUR AU - Portielje, J. E. AU - Kruit, W. H. AU - Eerenberg, A. J. AU - Schuler, M. AU - Sparreboom, A. AU - Lamers, C. H. PY - 2005 DA - 2005// TI - Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant JO - Cancer Immunol Immunother VL - 54 UR - https://doi.org/10.1007/s00262-004-0574-0 DO - 10.1007/s00262-004-0574-0 ID - Portielje2005 ER - TY - JOUR AU - Krist, L. F. AU - Kerremans, M. AU - Broekhuis-Fluitsma, D. M. AU - Eestermans, I. L. AU - Meyer, S. AU - Beelen, R. H. PY - 1998 DA - 1998// TI - Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity JO - Cancer Immunol Immunother VL - 47 UR - https://doi.org/10.1007/s002620050522 DO - 10.1007/s002620050522 ID - Krist1998 ER - TY - JOUR AU - Williams, R. AU - White, H. PY - 1986 DA - 1986// TI - The greater omentum: its applicability to cancer surgery and cancer therapy JO - Curr Probl Surg VL - 23 UR - https://doi.org/10.1016/0011-3840(86)90007-9 DO - 10.1016/0011-3840(86)90007-9 ID - Williams1986 ER - TY - JOUR AU - Beelen, R. H. AU - Fluitsma, D. M. AU - Hoefsmit, E. C. PY - 1980 DA - 1980// TI - The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and reticulum cells JO - J Reticuloendothel Soc VL - 28 ID - Beelen1980 ER - TY - JOUR AU - Trinchieri, G. AU - Scott, P. PY - 1995 DA - 1995// TI - Interleukin-12: a proinflammatory cytokine with immunoregulatory functions JO - Res Immunol VL - 146 UR - https://doi.org/10.1016/0923-2494(96)83011-2 DO - 10.1016/0923-2494(96)83011-2 ID - Trinchieri1995 ER - TY - JOUR AU - Kim, K. H. AU - Dmitriev, I. P. AU - Saddekni, S. AU - Kashentseva, E. A. AU - Harris, R. D. AU - Aurigemma, R. PY - 2013 DA - 2013// TI - A phase I clinical trial of Ad5/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer JO - Gynecol Oncol VL - 130 UR - https://doi.org/10.1016/j.ygyno.2013.06.003 DO - 10.1016/j.ygyno.2013.06.003 ID - Kim2013 ER - TY - JOUR AU - Kimball, K. J. AU - Preuss, M. A. AU - Barnes, M. N. AU - Wang, M. AU - Siegal, G. P. AU - Wan, W. PY - 2010 DA - 2010// TI - A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0791 DO - 10.1158/1078-0432.CCR-10-0791 ID - Kimball2010 ER - TY - JOUR AU - Coukos, G. AU - Makrigiannakis, A. AU - Kang, E. H. AU - Caparelli, D. AU - Benjamin, I. AU - Kaiser, L. R. PY - 1999 DA - 1999// TI - Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer JO - Clin Cancer Res VL - 5 ID - Coukos1999 ER - TY - JOUR AU - Coukos, G. AU - Makrigiannakis, A. AU - Montas, S. AU - Kaiser, L. R. AU - Toyozumi, T. AU - Benjamin, I. PY - 2000 DA - 2000// TI - Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy JO - Cancer Gene Ther VL - 7 UR - https://doi.org/10.1038/sj.cgt.7700130 DO - 10.1038/sj.cgt.7700130 ID - Coukos2000 ER - TY - JOUR AU - Andtbacka, R. H. AU - Kaufman, H. L. AU - Collichio, F. AU - Amatruda, T. AU - Senzer, N. AU - Chesney, J. PY - 2015 DA - 2015// TI - Talimogene Laherparepvec Improves Durable Response Rate in Patients with Advanced Melanoma JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.3377 DO - 10.1200/JCO.2014.58.3377 ID - Andtbacka2015 ER - TY - JOUR AU - Markert, J. M. AU - Cody, J. J. AU - Parker, J. N. AU - Coleman, J. M. AU - Price, K. H. AU - Kern, E. R. PY - 2012 DA - 2012// TI - Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12 JO - J Virol VL - 86 UR - https://doi.org/10.1128/JVI.06998-11 DO - 10.1128/JVI.06998-11 ID - Markert2012 ER - TY - JOUR AU - Martuza, R. L. AU - Malick, A. AU - Markert, J. M. AU - Ruffner, K. L. AU - Coen, D. M. PY - 1991 DA - 1991// TI - Experimental therapy of human glioma by means of a genetically engineered virus mutant JO - Science VL - 252 UR - https://doi.org/10.1126/science.1851332 DO - 10.1126/science.1851332 ID - Martuza1991 ER - TY - JOUR AU - Kramm, C. M. AU - Chase, M. AU - Herrlinger, U. AU - Jacobs, A. AU - Pechan, P. A. AU - Rainov, N. G. PY - 1997 DA - 1997// TI - Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy JO - Hum Gene Ther VL - 8 UR - https://doi.org/10.1089/hum.1997.8.17-2057 DO - 10.1089/hum.1997.8.17-2057 ID - Kramm1997 ER - TY - JOUR AU - Pyles, R. B. AU - Warnick, R. E. AU - Chalk, C. L. AU - Szanti, B. E. AU - Parysek, L. M. PY - 1997 DA - 1997// TI - A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors JO - Hum Gene Ther VL - 8 UR - https://doi.org/10.1089/hum.1997.8.5-533 DO - 10.1089/hum.1997.8.5-533 ID - Pyles1997 ER - TY - JOUR AU - Chambers, R. AU - Gillespie, G. Y. AU - Soroceanu, L. AU - Andreansky, S. AU - Chatterjee, S. AU - Chou, J. PY - 1995 DA - 1995// TI - Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma JO - Proc Natl Acad Sci U S A VL - 92 UR - https://doi.org/10.1073/pnas.92.5.1411 DO - 10.1073/pnas.92.5.1411 ID - Chambers1995 ER - TY - JOUR AU - Markert, J. M. AU - Malick, A. AU - Coen, D. M. AU - Martuza, R. L. PY - 1993 DA - 1993// TI - Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir JO - Neurosurgery VL - 32 UR - https://doi.org/10.1227/00006123-199304000-00016 DO - 10.1227/00006123-199304000-00016 ID - Markert1993 ER - TY - JOUR AU - Chou, J. AU - Roizman, B. PY - 1990 DA - 1990// TI - The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+ JO - J Virol VL - 64 ID - Chou1990 ER - TY - STD TI - Roth JC, Cassady KA, Cody JJ, Parker JN, Price KH, Coleman JM, et al. Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. Hum Gene Ther Clin Dev. 2014. ID - ref31 ER - TY - JOUR AU - Lv, L. AU - Zhang, T. AU - Yi, Q. AU - Huang, Y. AU - Wang, Z. AU - Hou, H. PY - 2012 DA - 2012// TI - Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.21196 DO - 10.4161/cc.21196 ID - Lv2012 ER - TY - JOUR AU - Roby, K. F. AU - Taylor, C. C. AU - Sweetwood, J. P. AU - Cheng, Y. AU - Pace, J. L. AU - Tawfik, O. PY - 2000 DA - 2000// TI - Development of a syngeneic mouse model for events related to ovarian cancer JO - Carcinogenesis VL - 21 UR - https://doi.org/10.1093/carcin/21.4.585 DO - 10.1093/carcin/21.4.585 ID - Roby2000 ER - TY - JOUR AU - Roberts, P. C. AU - Mottillo, E. P. AU - Baxa, A. C. AU - Heng, H. H. AU - Doyon-Reale, N. AU - Gregoire, L. PY - 2005 DA - 2005// TI - Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model JO - Neoplasia VL - 7 UR - https://doi.org/10.1593/neo.05358 DO - 10.1593/neo.05358 ID - Roberts2005 ER - TY - JOUR AU - McCloskey, C. W. AU - Goldberg, R. L. AU - Carter, L. E. AU - Gamwell, L. F. AU - Al-Hujaily, E. M. AU - Collins, O. PY - 2014 DA - 2014// TI - A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00053 DO - 10.3389/fonc.2014.00053 ID - McCloskey2014 ER - TY - JOUR AU - Landen, C. N. AU - Chavez-Reyes, A. AU - Bucana, C. AU - Schmandt, R. AU - Deavers, M. T. AU - Lopez-Berestein, G. PY - 2005 DA - 2005// TI - Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0530 DO - 10.1158/0008-5472.CAN-05-0530 ID - Landen2005 ER - TY - JOUR AU - Thaker, P. H. AU - Yazici, S. AU - Nilsson, M. B. AU - Yokoi, K. AU - Tsan, R. Z. AU - He, J. PY - 2005 DA - 2005// TI - Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2060 DO - 10.1158/1078-0432.CCR-04-2060 ID - Thaker2005 ER - TY - JOUR AU - Quinn, B. A. AU - Xiao, F. AU - Bickel, L. AU - Martin, L. AU - Hua, X. AU - Klein-Szanto, A. PY - 2010 DA - 2010// TI - Development of a syngeneic mouse model of epithelial ovarian cancer JO - J Ovarian Res VL - 3 UR - https://doi.org/10.1186/1757-2215-3-24 DO - 10.1186/1757-2215-3-24 ID - Quinn2010 ER - TY - JOUR AU - Connolly, D. C. AU - Bao, R. AU - Nikitin, A. Y. AU - Stephens, K. C. AU - Poole, T. W. AU - Hua, X. PY - 2003 DA - 2003// TI - Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer JO - Cancer Res VL - 63 ID - Connolly2003 ER - TY - JOUR AU - Hartkopf, A. D. AU - Fehm, T. AU - Wallwiener, D. AU - Lauer, U. PY - 2011 DA - 2011// TI - Oncolytic virotherapy of gynecologic malignancies JO - Gynecol Oncol VL - 120 UR - https://doi.org/10.1016/j.ygyno.2010.10.031 DO - 10.1016/j.ygyno.2010.10.031 ID - Hartkopf2011 ER - TY - JOUR AU - Benencia, F. AU - Courreges, M. C. AU - Conejo-Garcia, J. R. AU - Mohamed-Hadley, A. AU - Zhang, L. AU - Buckanovich, R. J. PY - 2005 DA - 2005// TI - HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer JO - Mol Ther VL - 12 UR - https://doi.org/10.1016/j.ymthe.2005.03.026 DO - 10.1016/j.ymthe.2005.03.026 ID - Benencia2005 ER - TY - JOUR AU - Fu, X. AU - Tao, L. AU - Zhang, X. PY - 2007 DA - 2007// TI - An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer JO - Cancer Gene Ther VL - 14 UR - https://doi.org/10.1038/sj.cgt.7701033 DO - 10.1038/sj.cgt.7701033 ID - Fu2007 ER - TY - JOUR AU - Wang, M. AU - Rancourt, C. AU - Navarro, J. G. AU - Krisky, D. AU - Marconi, P. AU - Oligino, T. PY - 1998 DA - 1998// TI - High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector JO - Gynecol Oncol VL - 71 UR - https://doi.org/10.1006/gyno.1998.5132 DO - 10.1006/gyno.1998.5132 ID - Wang1998 ER - TY - JOUR AU - Lenzi, R. AU - Edwards, R. AU - June, C. AU - Seiden, M. V. AU - Garcia, M. E. AU - Rosenblum, M. PY - 2007 DA - 2007// TI - Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma JO - J Transl Med VL - 5 UR - https://doi.org/10.1186/1479-5876-5-66 DO - 10.1186/1479-5876-5-66 ID - Lenzi2007 ER - TY - JOUR AU - Sorensen, E. W. AU - Gerber, S. A. AU - Sedlacek, A. L. AU - Rybalko, V. Y. AU - Chan, W. M. AU - Lord, E. M. PY - 2009 DA - 2009// TI - Omental immune aggregates and tumor metastasis within the peritoneal cavity JO - Immunol Res VL - 45 UR - https://doi.org/10.1007/s12026-009-8100-2 DO - 10.1007/s12026-009-8100-2 ID - Sorensen2009 ER - TY - JOUR AU - Fedorko, M. E. AU - Hirsch, J. G. PY - 1971 DA - 1971// TI - Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. I. Morphologic aspects JO - Exp Cell Res VL - 69 UR - https://doi.org/10.1016/0014-4827(71)90317-X DO - 10.1016/0014-4827(71)90317-X ID - Fedorko1971 ER - TY - JOUR AU - Kolodin, D. AU - Van Panhuys, N. AU - Li, C. AU - Magnuson, A. M. AU - Cipolletta, D. AU - Miller, C. M. PY - 2015 DA - 2015// TI - Antigen-and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice JO - Cell Metab VL - 21 UR - https://doi.org/10.1016/j.cmet.2015.03.005 DO - 10.1016/j.cmet.2015.03.005 ID - Kolodin2015 ER - TY - JOUR AU - Cipolletta, D. PY - 2014 DA - 2014// TI - Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential JO - Immunology VL - 142 UR - https://doi.org/10.1111/imm.12262 DO - 10.1111/imm.12262 ID - Cipolletta2014 ER - TY - JOUR AU - Cipolletta, D. AU - Cohen, P. AU - Spiegelman, B. M. AU - Benoist, C. AU - Mathis, D. PY - 2015 DA - 2015// TI - Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARgamma effects JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1423486112 DO - 10.1073/pnas.1423486112 ID - Cipolletta2015 ER - TY - JOUR AU - Cipolletta, D. AU - Kolodin, D. AU - Benoist, C. AU - Mathis, D. PY - 2011 DA - 2011// TI - Tissular T (regs): a unique population of adipose-tissue-resident Foxp3 + CD4+ T cells that impacts organismal metabolism JO - Semin Immunol VL - 23 UR - https://doi.org/10.1016/j.smim.2011.06.002 DO - 10.1016/j.smim.2011.06.002 ID - Cipolletta2011 ER - TY - JOUR AU - Burzyn, D. AU - Benoist, C. AU - Mathis, D. PY - 2013 DA - 2013// TI - Regulatory T cells in nonlymphoid tissues JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2683 DO - 10.1038/ni.2683 ID - Burzyn2013 ER - TY - JOUR AU - Molofsky, A. B. AU - Van Gool, F. AU - Liang, H. E. AU - Van Dyken, S. J. AU - Nussbaum, J. C. AU - Lee, J. PY - 2015 DA - 2015// TI - Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation JO - Immunity VL - 43 UR - https://doi.org/10.1016/j.immuni.2015.05.019 DO - 10.1016/j.immuni.2015.05.019 ID - Molofsky2015 ER - TY - JOUR AU - Rangel-Moreno, J. AU - Moyron-Quiroz, J. E. AU - Carragher, D. M. AU - Kusser, K. AU - Hartson, L. AU - Moquin, A. PY - 2009 DA - 2009// TI - Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens JO - Immunity VL - 30 UR - https://doi.org/10.1016/j.immuni.2009.03.014 DO - 10.1016/j.immuni.2009.03.014 ID - Rangel-Moreno2009 ER -